Nuveen Asset Management, LLC Blueprint Medicines Corp Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 281,014 shares of BPMC stock, worth $27.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
281,014
Previous 339,493 17.23%
Holding current value
$27.1 Million
Previous $36.6 Million 28.99%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$84.1 - $120.5 $4.92 Million - $7.05 Million
-58,479 Reduced 17.23%
281,014 $26 Million
Q2 2024

Aug 09, 2024
BUY
$85.18 - $108.78 $6.23 Million - $7.96 Million
73,146 Added 27.46%
339,493 $36.6 Million
Q1 2024

May 13, 2024
SELL
$73.17 - $99.79 $30,072 - $41,013
-411 Reduced 0.15%
266,347 $25.3 Million
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $3.98 Million - $8.4 Million
90,496 Added 51.34%
266,758 $24.6 Million
Q3 2023

Nov 14, 2023
BUY
$46.9 - $66.0 $90,751 - $127,710
1,935 Added 1.11%
176,262 $8.85 Million
Q2 2023

Aug 14, 2023
SELL
$42.2 - $66.37 $237,290 - $373,198
-5,623 Reduced 3.12%
174,327 $11 Million
Q1 2023

May 15, 2023
SELL
$37.97 - $50.0 $556,146 - $732,350
-14,647 Reduced 7.53%
179,950 $8.1 Million
Q4 2022

Feb 14, 2023
SELL
$41.06 - $66.48 $287,173 - $464,961
-6,994 Reduced 3.47%
194,597 $8.53 Million
Q3 2022

Nov 14, 2022
SELL
$49.93 - $77.7 $2.12 Million - $3.29 Million
-42,402 Reduced 17.38%
201,591 $13.3 Million
Q2 2022

Aug 15, 2022
BUY
$45.23 - $70.15 $652,940 - $1.01 Million
14,436 Added 6.29%
243,993 $12.3 Million
Q1 2022

May 16, 2022
SELL
$54.1 - $110.08 $7.35 Million - $15 Million
-135,898 Reduced 37.19%
229,557 $14.6 Million
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $446,462 - $549,444
4,737 Added 1.31%
365,455 $39.1 Million
Q3 2021

Nov 12, 2021
BUY
$80.98 - $109.47 $505,963 - $683,968
6,248 Added 1.76%
360,718 $37.1 Million
Q2 2021

Aug 16, 2021
BUY
$82.78 - $101.0 $7.13 Million - $8.7 Million
86,132 Added 32.1%
354,470 $31.2 Million
Q1 2021

May 17, 2021
SELL
$90.71 - $108.28 $716,971 - $855,845
-7,904 Reduced 2.86%
268,338 $26.1 Million
Q4 2020

May 17, 2021
BUY
$92.08 - $124.48 $2.12 Million - $2.87 Million
23,061 Added 9.11%
276,242 $31 Million
Q4 2020

Feb 16, 2021
SELL
$92.08 - $124.48 $3.06 Million - $4.14 Million
-33,270 Reduced 11.61%
253,181 $28.4 Million
Q3 2020

Nov 16, 2020
SELL
$66.45 - $92.7 $6.55 Million - $9.14 Million
-98,558 Reduced 25.6%
286,451 $26.6 Million
Q2 2020

Aug 14, 2020
SELL
$57.09 - $79.27 $1.77 Million - $2.45 Million
-30,926 Reduced 7.44%
385,009 $30 Million
Q1 2020

May 14, 2020
BUY
$48.11 - $82.22 $8.28 Million - $14.1 Million
172,088 Added 70.57%
415,935 $24.3 Million
Q4 2019

Feb 14, 2020
BUY
$66.73 - $82.59 $978,328 - $1.21 Million
14,661 Added 6.4%
243,847 $19.5 Million
Q3 2019

Nov 14, 2019
BUY
$72.9 - $101.41 $348,316 - $484,536
4,778 Added 2.13%
229,186 $16.8 Million
Q2 2019

Aug 15, 2019
BUY
$73.54 - $97.8 $15.7 Million - $20.8 Million
212,940 Added 1856.82%
224,408 $21.2 Million
Q1 2019

May 14, 2019
BUY
$48.7 - $86.6 $558,491 - $993,128
11,468 New
11,468 $918,000
Q3 2018

Nov 13, 2018
SELL
$58.91 - $78.32 $1.32 Million - $1.75 Million
-22,389 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$60.96 - $101.18 $693,602 - $1.15 Million
11,378 Added 103.33%
22,389 $1.42 Million
Q1 2018

May 14, 2018
SELL
$73.28 - $102.95 $396,078 - $556,444
-5,405 Reduced 32.93%
11,011 $1.01 Million
Q4 2017

Feb 14, 2018
SELL
$62.91 - $88.32 $138,150 - $193,950
-2,196 Reduced 11.8%
16,416 $0
Q3 2017

Nov 14, 2017
BUY
$42.37 - $69.67 $788,590 - $1.3 Million
18,612
18,612 $1.3 Million

Others Institutions Holding BPMC

# of Institutions
352
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.76B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email